Stock YCBD CBDMD, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials cbdMD, Inc.

Equities

YCBD

US12482W3097

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.8711 USD -3.21% Intraday chart for cbdMD, Inc. -12.89% -16.24%
Apr. 02 CbdMD, Inc. Appoints Brad Whitford as Chief Accounting Officer, Treasurer and Secretary CI
Mar. 29 Transcript : CbdMD, Inc. - Shareholder/Analyst Call

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 109.8 104.2 120.2 13.63 2.958 2.653 -
Enterprise Value (EV) 1 109.8 89.71 93.93 13.63 2.958 2.653 2.653
P/E ratio -1.4 x 7.14 x -4.43 x -0.18 x -0.08 x -0.4 x -1.81 x
Yield - - - - - - -
Capitalization / Revenue 4.64 x 2.49 x 2.7 x - 0.12 x 0.12 x 0.1 x
EV / Revenue 4.64 x 2.49 x 2.7 x - 0.12 x 0.12 x 0.1 x
EV / EBITDA -9,110,662 x -6,180,573 x -6,461,579 x - - - -
EV / FCF - -8,695,554 x -8,325,074 x - - - -
FCF Yield - -0% -0% - - - -
Price to Book - - - - - - -
Nbr of stocks (in thousands) 616 1,158 1,284 1,346 2,858 3,045 -
Reference price 2 178.2 90.00 93.60 10.13 1.035 0.8711 0.8711
Announcement Date 12/18/19 12/22/20 12/17/21 12/15/22 12/22/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Settembre 2019 2020 2021 2022 2023 2024 2025
Net sales 1 23.65 41.88 44.48 - 24.16 22.51 27.02
EBITDA -12.05 -16.86 -18.6 - - - -
EBIT 1 -14.8 -17.58 -19.62 - -5.527 -4.707 -2.517
Operating Margin -62.56% -41.98% -44.1% - -22.88% -20.91% -9.32%
Earnings before Tax (EBT) 1 -47.79 11.31 -24.29 - -22.94 -4.637 -2.517
Net income 1 -50.43 12.24 -25.95 -70.08 -26.94 -6.639 -2.517
Net margin -213.21% 29.21% -58.34% - -111.53% -29.49% -9.32%
EPS 2 -126.9 12.60 -21.15 -55.80 -13.32 -2.180 -0.4800
Free Cash Flow - -11.98 -14.44 - - - -
FCF margin - -28.61% -32.45% - - - -
FCF Conversion (EBITDA) - - - - - - -
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 12/18/19 12/22/20 12/17/21 12/15/22 12/22/23 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Settembre 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2023 Q1 2023 Q2 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 9.793 9.322 - 8.593 - - 5.711 5.375 5.403 5.714 6.022
EBITDA -6.715 -4.729 - - - - - - - - -
EBIT 1 -7.013 -25.15 - - - - -0.5721 -1.066 -1.297 -1.2 -1.144
Operating Margin -71.61% -269.74% - - - - -10.02% -19.83% -24.01% -21% -19%
Earnings before Tax (EBT) 1 -3.156 -19.16 - - - - -15.87 -0.9965 -1.297 -1.2 -1.144
Net income 1 -4.36 -20.16 -4.657 - - -1.77 -16.88 -1.997 -2.298 -1.2 -1.144
Net margin -44.52% -216.28% - - - - -295.5% -37.15% -42.53% -21% -19%
EPS 2 -1.800 -15.75 -4.500 -24.75 -3.600 -1.160 -9.060 -0.6700 -0.7500 -0.3900 -0.3600
Dividend per Share - - - - - - - - - - -
Announcement Date 12/17/21 2/10/22 5/13/22 8/11/22 2/13/23 8/10/23 12/22/23 2/13/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: Settembre 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - 14.5 26.2 - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow - -12 -14.4 - - - -
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1.2 1.32 0.34 - 0.3 - -
Capex / Sales 5.07% 3.15% 0.77% - 1.23% - -
Announcement Date 12/18/19 12/22/20 12/17/21 12/15/22 12/22/23 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for cbdMD, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8711 USD
Average target price
2 USD
Spread / Average Target
+129.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CBDMD, INC. Stock cbdMD, Inc.
-16.24% 2.65M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. YCBD Stock
  4. Financials cbdMD, Inc.